Nasdaq Halts KaloBios Pharmaceuticals, Inc.

NEW YORK, Dec. 17, 2015 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) at 06:48:07 Eastern Time for "additional information requested" from the company at a last price of $23.59.

Trading will remain halted until KaloBios Pharmaceuticals, Inc. has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Peter Gau
+1.212.231.5475
[email protected]

You May Also Be Interested In

• Fooyo Enterprise AI Brings Its AI Knowledge Base On-Premises With NVIDIA DGX Spark
• Barksdale Resources Releases Final Spring 2026 Program Results and Plans 8,000-Metre Fall 2026 Diamond Drill Program And ZTEM Survey
• Kakao Group Announces MoU with Fireblocks to Explore Digital Asset Opportunities in Korea